A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
IgA (Immunoglobulin A)
MessagePerforming Lab: Central Lab, Regions
Test Code
0515
Alias/See Also
Sunquest: IGA
CPT Codes
82784
Preferred Specimen
0.6 mL Lithium Heparin Plasma (light green-top) tube
Minimum Volume
0.3 mL
Other Acceptable Specimens
Serum separator (gold-top), Red, Red/Gray
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated: 7 days
Methodology
Immunoturbidimetric
Setup Schedule
Monday - Friday
Report Available
Same day
Limitations
Abnormally elevated levels of monoclonal immunoglobulin, as in cases of multiple myeloma, amyloidosis, or other lymphoproliferative diseases may interfere with the quantification of IgA
Reference Range
Age | Sex | Reference Range |
0-4 Months | Female | 1-34 |
4 Months-2 Years | Female | 8-91 |
2 Years-13 Years | Female | 21-282 |
13 Years-61 Years | Female | 65-421 |
Greater than 61 Years | Female | 69-517 |
0-4 Months | Male | 1-34 |
4 Months- 2 Years | Male | 8-91 |
2 Years - 13 Years | Male | 21-291 |
13 Years - 61 Years | Male | 63-484 |
Greater than 61 Years | Male | 101-645 |
Clinical Significance
IgA represents 10 to 15% of serum immunoglobulin. Despite the uncertainty of its exact role in serum, its part in resistance against infection is due to the prevention of adherence of bacteria, or to the inhibition of attachment and penetration of viruses. IgA may be elevated in recurrent infections and anaphylactic transfusion reactions. Increases are also associated with chronic liver disease, chronic infections, neoplasia of the lower GI tract and inflammatory bowel disease. IgA may be used as an aid in the diagnosis of ataxia telangiectasia, in the differentiation of M-components in multiple myeloma, and in the evaluation of progression of IgA myeloma. Decreased levels of IgA may be found in isolated genetic deficiency, combined immunodeficiency disorders, non-IgA multiple myeloma or macroglobulinemia.